| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Naphazoline hydrochloride (substance) |
Is a |
False |
Naphazoline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Naphazoline adverse reaction |
Causative agent (attribute) |
True |
Naphazoline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Allergy to naphazoline (finding) |
Causative agent (attribute) |
False |
Naphazoline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Respiratory naphazoline |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naphazoline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Naphazoline (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Naphazoline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing naphazoline and pheniramine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Naphazoline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Pheniramine 0.0315%/naphazoline 0.02675% ophthlamic solution (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naphazoline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing naphazoline and witch hazel (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Naphazoline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Naphazoline-containing product in nasal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Naphazoline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing naphazoline in ophthalmic dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naphazoline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Allergy to naphazoline (finding) |
Causative agent (attribute) |
True |
Naphazoline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Naphazoline nitrate |
Is a |
False |
Naphazoline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Naphazoline hydrochloride 250 microgram/mL and pheniramine maleate 3 mg/mL eye solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naphazoline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Naphazoline nitrate |
Is modification of (attribute) |
True |
Naphazoline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Naphazoline hydrochloride (substance) |
Is modification of (attribute) |
True |
Naphazoline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Naphazoline-containing product in pulmonary dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Naphazoline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Naphazoline-containing product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Naphazoline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only naphazoline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Naphazoline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Naphazoline and pheniramine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Naphazoline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Naphazoline and witch hazel only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Naphazoline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Naphazoline only product in nasal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Naphazoline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only naphazoline in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Naphazoline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Naphazoline only product in pulmonary dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Naphazoline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing naphazoline and pheniramine in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Naphazoline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Naphazoline and pheniramine only product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Naphazoline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Naphazoline- and polyvinyl alcohol- and zinc sulfate-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Naphazoline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only naphazoline and polyvinyl alcohol and zinc sulfate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Naphazoline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only lidocaine and naphazoline in oromucosal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Naphazoline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only lidocaine and naphazoline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Naphazoline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Lidocaine- and naphazoline-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Naphazoline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Lidocaine- and naphazoline-containing product in oromucosal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Naphazoline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.4-SNAPSHOT
|
FHIR Version n/a
User: [n/a]